Dxcover Limited is a Scottish company which was founded on 16 May 2016.[1] It is based in Glasgow, UK. It combines novel hardwares with artificial intelligence algorithms. Patients' blood samples are analysed by scientists to detect the presence of diseases. It is a clinical stage liquid biopsy company[2] and uses artificial intelligence algorithms for early detection of cancers and other diseases to improve survival rates. Its marketplaces are located in the US, UK and EU.[3] The company aims to detect early stage (Stage I and Stage II) of cancers.[4][5]
The company was previously named as ClinSpec Diagnostics Limited between 16 May 2016 and 26 April 2021.[1] It is spun out from the University of Strathclyde, Glasgow. After that, it is rebranded as Dxcover Limited in 2021.[1]
Technology
Dxcover has developed 'Drop, Dry, Detect' technology which technically detects and works in minutes to detect signs of cancer using artificial intelligence trained model.
Panoramic platform is a multi-omic spectral analysis (MOSA) technology[6] for various cancers which are brain, advanced adenoma, colorectal, and lung cancer. This technology analyses the signals that were missed by traditional cancer detection methods.[7]
For brain tumors, there is no biomarker test available. The test algorithm makes use of the complete biological profile of the patient's serum sample rather than concentrating on a single biomarker for illness. Results are accessible in minutes, and no specialized sample preparation is needed.[8]
Funding
Based on research conducted at Strathclyde University, Dxcover Limited has raised over £10 million for its technology that enables the early diagnosis of numerous malignancies.[9]
Existing investors lead by Eos Advisory LLP contributed £7.5 million in Series A funding, with further contributions from the University of Strathclyde, Mercia Fund Management, Scottish Enterprise, Social Investment Scotland Ventures, and Norcliffe Capital. As Dxcover continues to expand its U.S. network, Boston-based life science investor Mark Bamforth of Thairm Bio also joined the round.[9]
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
